Page last updated: 2024-11-04

sulfadiazine and Sarcoma 180

sulfadiazine has been researched along with Sarcoma 180 in 2 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Sarcoma 180: An experimental sarcoma of mice.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, Z1
Yang, G1
Lin, Z1
Huang, J1
Abel, G1
Connors, TA1
Ross, WC1
Hoellinger, H1
Pichat, L1

Other Studies

2 other studies available for sulfadiazine and Sarcoma 180

ArticleYear
2-[N1-2-pyrimidyl-aminobenzenesulfonamido] ethyl 4-bis(2-chloroethyl) aminophenyl butyrate: a potent antitumor agent.
    Bioorganic & medicinal chemistry letters, 2001, May-07, Volume: 11, Issue:9

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzenesulfonates; Chlorambucil;

2001
The selective concentration of sulphadiazine and related compounds in malignant tissue.
    European journal of cancer, 1973, Volume: 9, Issue:1

    Topics: Animals; Carbon Isotopes; Carcinoma 256, Walker; Female; Hydrogen-Ion Concentration; Liver; Lymphoma

1973